Skip to main content

Table 1 Data extracted from "published series"

From: Safety of percutaneous aortic valve insertion. A systematic review

Reference Time window n Age in years mean ± SD (median: IQR) Logistic EuroSCORE mean ± SD (median: IQR) STS score Device, approach Success rate (%) 30-d mort (%) 6-m mort (%)
[27] Jan 2005 - July 2005 18 81 ± 6 26.2 ± 13.1 NA Ed, TF 77.8 11.1 NA
[23] Jan 2005 - NA 50 82 ± 7 28 NA Ed, TF 86 12 18
[28] Feb 2005 - Nov 2005 25 80.3 ± 5.4 (10.97:19.90-9.20) NA CV, TF 84 20 NA
[29] March 2005 - Aug 2006 11 81.8 ± 6.8 (36: 5-48) NA CV, TF 100 18.2 NA
[30] Aug 2005 - Feb 2007 86 82.2 ± 5.9 21.7 ± 12.6 NA CV, TF 88 12 NA
[31] Oct 2005 - NA 7 63-91 range: 7-66 NA Ed, TA 100 14.3 42.8
[32 Oct 2005 - NA 7 63-91 range: 7-66 NA Ed, TA § § §
[33] Dec 2005 - Aug 2006 10 (81.3: 64-85) (32: 21-40) NA CV, TF 100 20 NA
[34] Feb 2006 - Sep 2006 30 82 ± 5 27.1 ± 12.2 NA Ed, TA 96.6 6.6 NA
[35] Feb 2006 - March 2007 50 82.4 ± 4.6 276 ± 12.2 15.8 ± 9.1 Ed, TA 94 8 26.1
[21] Feb 2006 - Oct 2006 59 81.4 ± 5.8 26.8 ± 13.5 NA Ed, TA 93.2 13.6 NA
[36] Feb 2006 - Feb 2008 26 84 ± 7 36.5 ± 5.8 NA Ed, TA 100 15 NA
[37] Oct 2006 - Apr 2007 12 85 ± 6 31.1 ± 14.4 18.8 ± 4.3 Ed, TF 83 25 25
[14] Dec 2006 - Feb 2008 40 83 ± 7.5 35.5 ± 15.3 13.4 Ed, TA 87.5 17.5 41.3
[38] April 2007 - January 2008 22 84 ± 7 26 ± 16*   Ed, TF+TA 91 9.1 NA
  1. NA: not available. Ed: Edwards Lifesciences device (or any of its predecessors). CV: CoreValve Revalving System. TF: transfemoral. TA: transapical. § 6-month follow-up of data from [31] *: risk estimation tool not mentioned. SD: standard deviation. IRQ: interquartile range. NA: not available. Success: % of attempted successful. STS: Society of Thoracic Surgeons.